首页 > 最新文献

European Journal of Clinical Microbiology & Infectious Diseases最新文献

英文 中文
Silent risk: the vertical transmission of Oropouche virus. 无声的风险:奥罗波切病毒的垂直传播。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-06 DOI: 10.1007/s10096-024-04975-9
Kukreja Garima S, Khopkar-Kale Priyanka S, Tripathy Srikanth P, Bhawalkar Jitendra S

The Oropouche virus (OROV), a member of the Orthobunyavirus genus, poses a significant public health challenge due to its potential for vertical transmission and lack of approved vaccines or antiviral treatments. Recent outbreaks have highlighted the association of OROV infection in pregnant women with severe outcomes, including spontaneous abortions, congenital anomalies, and fetal deaths. This letter to the editor emphasizes the need for a multifaceted approach to address the potential for vertical transmission of OROV, including the use of small animal models, detailed pathological studies, and robust preventive measures. We stress the importance of increased clinician awareness, timely patient management, and a One Health surveillance program to mitigate the risks associated with OROV infection during pregnancy.

奥罗普切病毒(OROV)是正粘病毒属的一种病毒,由于其具有垂直传播的潜力,且缺乏经批准的疫苗或抗病毒治疗方法,因此对公共卫生构成了重大挑战。最近的疫情突出表明,孕妇感染 OROV 会导致严重后果,包括自然流产、先天畸形和胎儿死亡。这封致编辑的信强调,需要采取多方面的措施来应对 OROV 垂直传播的可能性,包括使用小动物模型、进行详细的病理研究和采取有力的预防措施。我们强调,提高临床医生的认识、及时处理患者以及实施 "一体健康 "监测计划对于降低孕期感染奥罗莫病毒的风险非常重要。
{"title":"Silent risk: the vertical transmission of Oropouche virus.","authors":"Kukreja Garima S, Khopkar-Kale Priyanka S, Tripathy Srikanth P, Bhawalkar Jitendra S","doi":"10.1007/s10096-024-04975-9","DOIUrl":"https://doi.org/10.1007/s10096-024-04975-9","url":null,"abstract":"<p><p>The Oropouche virus (OROV), a member of the Orthobunyavirus genus, poses a significant public health challenge due to its potential for vertical transmission and lack of approved vaccines or antiviral treatments. Recent outbreaks have highlighted the association of OROV infection in pregnant women with severe outcomes, including spontaneous abortions, congenital anomalies, and fetal deaths. This letter to the editor emphasizes the need for a multifaceted approach to address the potential for vertical transmission of OROV, including the use of small animal models, detailed pathological studies, and robust preventive measures. We stress the importance of increased clinician awareness, timely patient management, and a One Health surveillance program to mitigate the risks associated with OROV infection during pregnancy.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142581494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal incubation duration of liquid cultures for assessing culture negative conversion in patients with Mycobacterium avium complex and Mycobacterium abscessus pulmonary diseases. 评估分枝杆菌复合体和脓肿分枝杆菌肺部疾病患者培养阴转的液体培养最佳培养时间。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-05 DOI: 10.1007/s10096-024-04973-x
Yoshifumi Uwamino, Naoki Hasegawa, Yuka Kamoshita, Rika Inose, Wataru Aoki, Mika Nagata, Ho Namkoong, Tomoyasu Nishimura, Hiromichi Matsushita

Purpose: Mycobacterial liquid culturing typically requires six weeks or longer, primarily because of the slow growth rate of Mycobacterium tuberculosis. This study aimed to evaluate the potential of shortening the duration of mycobacterial liquid culturing in healthcare settings with high prevalence rates of non-tuberculous mycobacteria.

Methods: We retrospectively analyzed the relationship between mycobacterial species and time to positive testing of liquid cultures from sputum samples using the Mycobacteria Growth Indicator Tube system over a 3.5-year period beginning in July 2020 at a university hospital in Japan.

Results: We analyzed 15,147 sputum culture samples and found a 1.1% positivity rate for Mycobacterium tuberculosis complex, while the rates for Mycobacterium avium complex and Mycobacterium abscessus were 17.6% and 2.1%, respectively. The median time to positivity was 17 days for Mycobacterium tuberculosis complex, 9 days for Mycobacterium avium complex, and 4 days for Mycobacterium abscessus. Comparing a 4-week culture period with an eight-week period, the positivity rates for Mycobacterium avium complex and Mycobacterium abscessus were 97.0% and 99.4%, respectively.

Conclusion: In settings with a high incidence of non-tuberculous mycobacteria, the basic liquid culturing period can be safely shortened to 4 weeks without significantly compromising detection sensitivity, except for the samples that are highly suspected to contain tuberculosis, extremely slow-growing mycobacteria, smear-positive, or nucleic acid amplification testing positive.

目的:分枝杆菌液体培养通常需要六周或更长时间,这主要是因为结核分枝杆菌的生长速度较慢。本研究旨在评估在非结核分枝杆菌感染率较高的医疗机构缩短分枝杆菌液体培养时间的可能性:我们回顾性地分析了日本一所大学医院自 2020 年 7 月起的 3.5 年间,使用分枝杆菌生长指示管系统对痰液样本进行分枝杆菌种类和液体培养阳性检测时间之间的关系:我们分析了 15,147 份痰培养样本,发现结核分枝杆菌复合体的阳性率为 1.1%,而鸟分枝杆菌复合体和脓肿分枝杆菌的阳性率分别为 17.6% 和 2.1%。复合结核分枝杆菌阳性的中位时间为 17 天,禽分枝杆菌为 9 天,脓肿分枝杆菌为 4 天。将 4 周的培养期与 8 周的培养期相比,复合分枝杆菌和脓肿分枝杆菌的阳性率分别为 97.0% 和 99.4%:结论:在非结核分枝杆菌发病率较高的环境中,基本液体培养时间可安全地缩短至 4 周,而不会明显影响检测灵敏度,但高度怀疑含有结核病、生长极其缓慢的分枝杆菌、涂片阳性或核酸扩增检测阳性的样本除外。
{"title":"Optimal incubation duration of liquid cultures for assessing culture negative conversion in patients with Mycobacterium avium complex and Mycobacterium abscessus pulmonary diseases.","authors":"Yoshifumi Uwamino, Naoki Hasegawa, Yuka Kamoshita, Rika Inose, Wataru Aoki, Mika Nagata, Ho Namkoong, Tomoyasu Nishimura, Hiromichi Matsushita","doi":"10.1007/s10096-024-04973-x","DOIUrl":"https://doi.org/10.1007/s10096-024-04973-x","url":null,"abstract":"<p><strong>Purpose: </strong>Mycobacterial liquid culturing typically requires six weeks or longer, primarily because of the slow growth rate of Mycobacterium tuberculosis. This study aimed to evaluate the potential of shortening the duration of mycobacterial liquid culturing in healthcare settings with high prevalence rates of non-tuberculous mycobacteria.</p><p><strong>Methods: </strong>We retrospectively analyzed the relationship between mycobacterial species and time to positive testing of liquid cultures from sputum samples using the Mycobacteria Growth Indicator Tube system over a 3.5-year period beginning in July 2020 at a university hospital in Japan.</p><p><strong>Results: </strong>We analyzed 15,147 sputum culture samples and found a 1.1% positivity rate for Mycobacterium tuberculosis complex, while the rates for Mycobacterium avium complex and Mycobacterium abscessus were 17.6% and 2.1%, respectively. The median time to positivity was 17 days for Mycobacterium tuberculosis complex, 9 days for Mycobacterium avium complex, and 4 days for Mycobacterium abscessus. Comparing a 4-week culture period with an eight-week period, the positivity rates for Mycobacterium avium complex and Mycobacterium abscessus were 97.0% and 99.4%, respectively.</p><p><strong>Conclusion: </strong>In settings with a high incidence of non-tuberculous mycobacteria, the basic liquid culturing period can be safely shortened to 4 weeks without significantly compromising detection sensitivity, except for the samples that are highly suspected to contain tuberculosis, extremely slow-growing mycobacteria, smear-positive, or nucleic acid amplification testing positive.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142581474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a predictive model for in-hospital mortality from perioperative bacteremia in gastrointestinal surgery. 胃肠道手术围手术期菌血症院内死亡率预测模型的开发与验证。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-01 Epub Date: 2024-09-03 DOI: 10.1007/s10096-024-04926-4
Yusuke Taki, Shinsuke Sato, Masaya Watanabe, Ko Ohata, Hideyuki Kanemoto, Noriyuki Oba

Purpose: Prognostic scores require fluctuating values, such as respiratory rate, which are unsuitable for retrospective auditing. Therefore, this study aimed to develop and validate a predictive model for in-hospital mortality associated with gastrointestinal surgery for retrospective auditing.

Methods: Data from patients with bacteremia related to gastrointestinal surgery performed at Shizuoka General Hospital between July 2006 and December 2021 were extracted from a prospectively maintained database. Patients suspected of having a positive blood culture with contaminating bacteria or missing laboratory data were excluded. The remaining patients were randomly assigned in a 2:1 ratio to the deviation and validation cohorts. A logistic regression model estimated the odds ratios (ORs) and created a predictive model for in-hospital mortality. The model was evaluated using receiver operating characteristic (ROC) curves and calibration plots.

Results: Of 20,637 gastrointestinal surgeries, 398 resulted in bacteremia. The median age of patients with bacteremia was 72 years, and 66.1% were male. The most common pathogens were Staphylococcus (13.9%), followed by Bacteroides (12.4%) and Escherichia (11.4%). Multivariable logistic regression showed that creatinine abnormality (P < 0.001, OR = 3.39), decreased prognostic nutritional index (P < 0.001, OR = 0.90/unit), and age ≥ 75 years (P = 0.026, OR = 2.89) were independent prognostic factors for in-hospital mortality. The area under the ROC curve of the predictive model was 0.711 in the validation cohort. The calibration plot revealed that the model slightly overestimated mortality in the validation cohort.

Conclusions: Using age, creatinine level, albumin level, and lymphocyte count, the model accurately predicted in-hospital mortality after bacteremia infection related to gastrointestinal surgery, demonstrating its suitability for retrospective audits.

目的:预后评分需要呼吸频率等波动值,不适合进行回顾性审核。因此,本研究旨在开发并验证胃肠道手术相关院内死亡率的预测模型,以便进行回顾性审核:方法:从静冈综合医院的前瞻性数据库中提取2006年7月至2021年12月期间与胃肠道手术相关的菌血症患者的数据。排除了疑似血培养阳性的污染菌或实验室数据缺失的患者。其余患者按 2:1 的比例随机分配到偏差组和验证组。逻辑回归模型估算了几率比(OR),并建立了院内死亡率预测模型。该模型使用接收器操作特征曲线(ROC)和校准图进行评估:在 20637 例胃肠道手术中,有 398 例导致菌血症。菌血症患者的中位年龄为 72 岁,66.1% 为男性。最常见的病原体是葡萄球菌(13.9%),其次是杆菌(12.4%)和埃希氏菌(11.4%)。多变量逻辑回归显示,血肌酐异常(P 结论:血肌酐异常是一种常见的病原体:该模型利用年龄、肌酐水平、白蛋白水平和淋巴细胞计数准确预测了与胃肠道手术相关的菌血症感染后的院内死亡率,证明其适用于回顾性审计。
{"title":"Development and validation of a predictive model for in-hospital mortality from perioperative bacteremia in gastrointestinal surgery.","authors":"Yusuke Taki, Shinsuke Sato, Masaya Watanabe, Ko Ohata, Hideyuki Kanemoto, Noriyuki Oba","doi":"10.1007/s10096-024-04926-4","DOIUrl":"10.1007/s10096-024-04926-4","url":null,"abstract":"<p><strong>Purpose: </strong>Prognostic scores require fluctuating values, such as respiratory rate, which are unsuitable for retrospective auditing. Therefore, this study aimed to develop and validate a predictive model for in-hospital mortality associated with gastrointestinal surgery for retrospective auditing.</p><p><strong>Methods: </strong>Data from patients with bacteremia related to gastrointestinal surgery performed at Shizuoka General Hospital between July 2006 and December 2021 were extracted from a prospectively maintained database. Patients suspected of having a positive blood culture with contaminating bacteria or missing laboratory data were excluded. The remaining patients were randomly assigned in a 2:1 ratio to the deviation and validation cohorts. A logistic regression model estimated the odds ratios (ORs) and created a predictive model for in-hospital mortality. The model was evaluated using receiver operating characteristic (ROC) curves and calibration plots.</p><p><strong>Results: </strong>Of 20,637 gastrointestinal surgeries, 398 resulted in bacteremia. The median age of patients with bacteremia was 72 years, and 66.1% were male. The most common pathogens were Staphylococcus (13.9%), followed by Bacteroides (12.4%) and Escherichia (11.4%). Multivariable logistic regression showed that creatinine abnormality (P < 0.001, OR = 3.39), decreased prognostic nutritional index (P < 0.001, OR = 0.90/unit), and age ≥ 75 years (P = 0.026, OR = 2.89) were independent prognostic factors for in-hospital mortality. The area under the ROC curve of the predictive model was 0.711 in the validation cohort. The calibration plot revealed that the model slightly overestimated mortality in the validation cohort.</p><p><strong>Conclusions: </strong>Using age, creatinine level, albumin level, and lymphocyte count, the model accurately predicted in-hospital mortality after bacteremia infection related to gastrointestinal surgery, demonstrating its suitability for retrospective audits.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142119274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An insight on the powerful of bacterial quorum sensing inhibition. 洞察细菌法定人数感应的强大抑制作用。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-01 Epub Date: 2024-08-19 DOI: 10.1007/s10096-024-04920-w
Nourhan G Naga, Mona I Shaaban, Mohammad Magdy El-Metwally

Bacteria have their own language through which they communicate with one another like all higher organisms. So, many researchers are working hard to identify and comprehend the components of this bacterial communication, known as quorum sensing (QS). In quorum sensing, bacteria use signaling molecules called autoinducers (AIs) to exchange information. Many natural compounds and extraction techniques have been intensively studied to disrupt bacterial signaling and examine their effectiveness for bacterial pathogenesis control. Quorum sensing inhibitors can interfere with QS and block the action of AI signaling molecules. Recent research indicates that quorum sensing inhibitors (QSIs) and quorum quenching enzymes (QQEs) show great promise in reducing the pathogenicity of bacteria and inhibiting biofilm synthesis. In addition, the effectiveness of QQEs and QSIs in experimental animal models was demonstrated. These are taken into account in the development of innovative medical devices, such as dressings and catheters, to prevent bacterial infections. The present review highlights this aspect with a prospective vision for its development and application.

与所有高等生物一样,细菌也有自己的语言,它们通过这种语言相互交流。因此,许多研究人员正在努力识别和理解这种细菌交流的组成部分,即法定人数感应(QS)。在法定人数感应中,细菌使用称为自动诱导剂(AIs)的信号分子来交换信息。人们对许多天然化合物和提取技术进行了深入研究,以破坏细菌的信号传递,并检验它们在控制细菌致病机理方面的有效性。法定人数感应抑制剂可以干扰 QS 并阻断 AI 信号分子的作用。最新研究表明,法定人数感应抑制剂(QSIs)和法定人数淬灭酶(QQEs)在降低细菌致病性和抑制生物膜合成方面大有可为。此外,QQEs 和 QSIs 在动物实验模型中的有效性也得到了证实。在开发创新型医疗设备(如敷料和导管)以防止细菌感染时,这些都被考虑在内。本综述强调了这一方面,并对其开发和应用进行了展望。
{"title":"An insight on the powerful of bacterial quorum sensing inhibition.","authors":"Nourhan G Naga, Mona I Shaaban, Mohammad Magdy El-Metwally","doi":"10.1007/s10096-024-04920-w","DOIUrl":"10.1007/s10096-024-04920-w","url":null,"abstract":"<p><p>Bacteria have their own language through which they communicate with one another like all higher organisms. So, many researchers are working hard to identify and comprehend the components of this bacterial communication, known as quorum sensing (QS). In quorum sensing, bacteria use signaling molecules called autoinducers (AIs) to exchange information. Many natural compounds and extraction techniques have been intensively studied to disrupt bacterial signaling and examine their effectiveness for bacterial pathogenesis control. Quorum sensing inhibitors can interfere with QS and block the action of AI signaling molecules. Recent research indicates that quorum sensing inhibitors (QSIs) and quorum quenching enzymes (QQEs) show great promise in reducing the pathogenicity of bacteria and inhibiting biofilm synthesis. In addition, the effectiveness of QQEs and QSIs in experimental animal models was demonstrated. These are taken into account in the development of innovative medical devices, such as dressings and catheters, to prevent bacterial infections. The present review highlights this aspect with a prospective vision for its development and application.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141999622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two cases of Francisella tularensis subspecies holartica prosthetic valve endocarditis, and review of the literature. 两例土拉弗氏菌 Holarctica 亚种人工瓣膜心内膜炎病例及文献综述。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-01 Epub Date: 2024-09-06 DOI: 10.1007/s10096-024-04931-7
Jean-Philippe Talarmin, Schéhérazade Rezig, Lucia Grandiere Perez, Mathilde Artus, Sophie Blanchi, Brice Guerpillon, Aurélie Beaudron, Sandrine Boisset, Vincent Dubée, Yvan Caspar

Francisella tularensis endocarditis is rare and difficult to diagnose, and only a few cases have been described. We report two new cases of endocarditis due to F. tularensis subsp. holarctica, with a favorable evolution after appropriate antibiotic therapy and valve replacement surgery, and review the 5 other cases reported in the literature. This rare infection may be suspected based on the local epidemiology and the patient's exposure factors. A regimen of ciprofloxacin and gentamicin, combined with surgical valve replacement if necessary, appears to be effective in treating F. tularensis endocarditis.

土拉弗氏菌心内膜炎罕见且难以诊断,目前仅有少数病例被描述过。我们报告了两例新发的土拉弗氏菌洞穴亚种心内膜炎病例,经过适当的抗生素治疗和瓣膜置换手术后病情得到了良好的发展,并回顾了文献中报道的其他 5 例病例。根据当地的流行病学和患者的接触因素,可以怀疑这种罕见的感染。环丙沙星和庆大霉素治疗方案,必要时结合外科瓣膜置换术,似乎对治疗土拉菌心内膜炎有效。
{"title":"Two cases of Francisella tularensis subspecies holartica prosthetic valve endocarditis, and review of the literature.","authors":"Jean-Philippe Talarmin, Schéhérazade Rezig, Lucia Grandiere Perez, Mathilde Artus, Sophie Blanchi, Brice Guerpillon, Aurélie Beaudron, Sandrine Boisset, Vincent Dubée, Yvan Caspar","doi":"10.1007/s10096-024-04931-7","DOIUrl":"10.1007/s10096-024-04931-7","url":null,"abstract":"<p><p>Francisella tularensis endocarditis is rare and difficult to diagnose, and only a few cases have been described. We report two new cases of endocarditis due to F. tularensis subsp. holarctica, with a favorable evolution after appropriate antibiotic therapy and valve replacement surgery, and review the 5 other cases reported in the literature. This rare infection may be suspected based on the local epidemiology and the patient's exposure factors. A regimen of ciprofloxacin and gentamicin, combined with surgical valve replacement if necessary, appears to be effective in treating F. tularensis endocarditis.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linezolid in enterococcal urinary tract infection: a multicentre study. 利奈唑胺治疗肠球菌尿路感染:一项多中心研究。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-01 Epub Date: 2024-08-21 DOI: 10.1007/s10096-024-04923-7
Léa Malinowski, Souheil Zayet, Myriam Chiaruzzi, Benjamin Lefevre, Guillaume Baronnet, Mathieu Blot, Timothée Klopfenstein, Lionel Piroth, Catherine Chirouze, Albert Sotto, Kevin Bouiller

Purpose: Few data have been published on the efficacy of linezolid in enterococcal urinary tract infection (e-UTI). The aims of this study were to describe the characteristics of patients with enterococci UTI treated with linezolid, and to evaluate the efficacy and the tolerance of linezolid treatment.

Methods: An observational multicentre retrospective study was conducted in 5 hospitals in France. Patients were included if they met the following criteria: ≥18 years, clinical and microbiological criteria for enterococcal UTI and linezolid treatment > 48 h. Primary outcome was clinical failure.

Results: Eighty-one patients were included between January 2015 and December 2021. The median age was 73.0 [64; 83] years and 47 (58%) were men. The median Charlson comorbidity index was 3.00 [2; 6]. E. faecium was reported in 65 (80%) cases and E. faecalis in 26 cases (32%). Polymicrobial infections occurred in 41 (51%) cases. No enterococci was resistant to vancomycin. Before linezolid prescription an empiric antimicrobial treatment was started in 48 (59%) cases and was effective against enterococci in 19/48 (39.5%) patients for a median of 3.5 days [2.0; 4.0]. The median duration of linezolid antibiotic treatment was 13 days [10; 14]. Three adverse events were reported, none were serious but one led to discontinuation of treatment. Treatment failure was reported in 2 cases (2.5%).

Conclusion: This study provides evidence for efficacy and safety of linezolid in enterococcal UTI.

目的:有关利奈唑胺治疗肠球菌尿路感染(e-UTI)疗效的数据很少。本研究旨在描述接受利奈唑胺治疗的肠球菌尿路感染患者的特征,并评估利奈唑胺治疗的疗效和耐受性:在法国的 5 家医院开展了一项多中心回顾性观察研究。符合以下条件的患者均被纳入研究:年龄≥18 岁,符合肠球菌性尿路感染的临床和微生物学标准,利奈唑胺治疗时间大于 48 小时:结果:2015 年 1 月至 2021 年 12 月期间纳入了 81 名患者。中位年龄为 73.0 [64; 83]岁,男性 47 人(58%)。夏尔森合并症指数中位数为 3.00 [2; 6]。据报告,65 例(80%)感染了粪肠球菌,26 例(32%)感染了粪肠球菌。41例(51%)发生了多微生物感染。没有肠球菌对万古霉素产生耐药性。在开具利奈唑胺处方前,48 例(59%)患者开始接受经验性抗菌治疗,其中 19/48 例(39.5%)患者接受了有效的肠球菌抗菌治疗,治疗时间中位数为 3.5 天 [2.0; 4.0]。利奈唑胺抗生素治疗的中位持续时间为 13 天 [10; 14]。共报告了三例不良反应,均不严重,但其中一例导致治疗中断。2例(2.5%)治疗失败:本研究为利奈唑胺治疗肠球菌性尿路感染的有效性和安全性提供了证据。
{"title":"Linezolid in enterococcal urinary tract infection: a multicentre study.","authors":"Léa Malinowski, Souheil Zayet, Myriam Chiaruzzi, Benjamin Lefevre, Guillaume Baronnet, Mathieu Blot, Timothée Klopfenstein, Lionel Piroth, Catherine Chirouze, Albert Sotto, Kevin Bouiller","doi":"10.1007/s10096-024-04923-7","DOIUrl":"10.1007/s10096-024-04923-7","url":null,"abstract":"<p><strong>Purpose: </strong>Few data have been published on the efficacy of linezolid in enterococcal urinary tract infection (e-UTI). The aims of this study were to describe the characteristics of patients with enterococci UTI treated with linezolid, and to evaluate the efficacy and the tolerance of linezolid treatment.</p><p><strong>Methods: </strong>An observational multicentre retrospective study was conducted in 5 hospitals in France. Patients were included if they met the following criteria: ≥18 years, clinical and microbiological criteria for enterococcal UTI and linezolid treatment > 48 h. Primary outcome was clinical failure.</p><p><strong>Results: </strong>Eighty-one patients were included between January 2015 and December 2021. The median age was 73.0 [64; 83] years and 47 (58%) were men. The median Charlson comorbidity index was 3.00 [2; 6]. E. faecium was reported in 65 (80%) cases and E. faecalis in 26 cases (32%). Polymicrobial infections occurred in 41 (51%) cases. No enterococci was resistant to vancomycin. Before linezolid prescription an empiric antimicrobial treatment was started in 48 (59%) cases and was effective against enterococci in 19/48 (39.5%) patients for a median of 3.5 days [2.0; 4.0]. The median duration of linezolid antibiotic treatment was 13 days [10; 14]. Three adverse events were reported, none were serious but one led to discontinuation of treatment. Treatment failure was reported in 2 cases (2.5%).</p><p><strong>Conclusion: </strong>This study provides evidence for efficacy and safety of linezolid in enterococcal UTI.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in human papillomavirus infection and genotype distribution among males in Chongqing, China (2017-2022): an observational study. 中国重庆市男性人类乳头瘤病毒感染趋势及基因型分布(2017-2022年):一项观察性研究。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-01 Epub Date: 2024-09-04 DOI: 10.1007/s10096-024-04933-5
Xiyang Yi, Hongjiao Chen, Guangjie Wu, Yanqi Hu, Xiaojun Tang

Purpose: This study aimed to investigate Human papillomavirus (HPV) infection and genotyping in men from Chongqing and analyze age-related trends to provide insights for HPV prevention and vaccination plans tailored for men in Chongqing, China.

Methods: This study is an observational study. We investigated male patients who underwent HPV screening at two hospitals in Chongqing from 2017 to 2022, totaling 4,381 cases, aged 18 to 85. HPV genotyping was conducted using the Hybribio Rapid GenoArray kit.

Results: Among the 4,381 men, the overall HPV prevalence was 14.9%, peaking at 19.3% in 2022. Single HPV infection was 11.5%, and multiple infection was 3.4%. The most prevalent genotypes were HPV-52, HPV-16, and HPV-58. Single high-risk HPV infection peaked in the 36-45 age group, while multiple high-risk HPV infection decreased with age (P-trend < 0.01). Prevalence in the ≤ 25 age group was 3.7%. Single low-risk HPV infection also decreased with age (P-trend = 0.03). Genotypes covered by the nonavalent vaccine had the highest prevalence, increasing with age. Co-infection of HPV-16 with HPV-52 and HPV-58 was common. Single HPV infections were prevalent in cases of urethritis (30.8%), anogenital warts (36.4%), and genital warts (26.3%), while multiple HPV infections were significant in anogenital warts (18.2%).

Conclusions: Single HPV infection was predominant in Chongqing, with HPV-52, HPV-16, HPV-58, HPV-53, and HPV-39 being the most prevalent genotypes. The prevalence of genotypes covered by the nonavalent vaccine increased with age. This study offers valuable insights for developing male-specific HPV prevention strategies in Chongqing.

目的:本研究旨在调查重庆男性的人乳头瘤病毒(HPV)感染情况和基因分型,并分析与年龄相关的趋势,从而为重庆男性的HPV预防和疫苗接种计划提供见解:本研究是一项观察性研究。我们调查了2017年至2022年在重庆两家医院接受HPV筛查的男性患者,共计4381例,年龄在18岁至85岁之间。HPV基因分型采用Hybribio Rapid GenoArray试剂盒进行:结果:在 4381 名男性中,HPV 的总体感染率为 14.9%,2022 年达到峰值 19.3%。单一 HPV 感染率为 11.5%,多重感染率为 3.4%。最流行的基因型是 HPV-52、HPV-16 和 HPV-58。单一高危 HPV 感染在 36-45 岁年龄组达到高峰,而多重高危 HPV 感染则随着年龄的增长而减少(P-趋势结论):在重庆,单一HPV感染占主导地位,HPV-52、HPV-16、HPV-58、HPV-53和HPV-39是最流行的基因型。无价疫苗所覆盖基因型的流行率随着年龄的增长而增加。这项研究为重庆市制定针对男性的HPV预防策略提供了宝贵的见解。
{"title":"Trends in human papillomavirus infection and genotype distribution among males in Chongqing, China (2017-2022): an observational study.","authors":"Xiyang Yi, Hongjiao Chen, Guangjie Wu, Yanqi Hu, Xiaojun Tang","doi":"10.1007/s10096-024-04933-5","DOIUrl":"10.1007/s10096-024-04933-5","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate Human papillomavirus (HPV) infection and genotyping in men from Chongqing and analyze age-related trends to provide insights for HPV prevention and vaccination plans tailored for men in Chongqing, China.</p><p><strong>Methods: </strong>This study is an observational study. We investigated male patients who underwent HPV screening at two hospitals in Chongqing from 2017 to 2022, totaling 4,381 cases, aged 18 to 85. HPV genotyping was conducted using the Hybribio Rapid GenoArray kit.</p><p><strong>Results: </strong>Among the 4,381 men, the overall HPV prevalence was 14.9%, peaking at 19.3% in 2022. Single HPV infection was 11.5%, and multiple infection was 3.4%. The most prevalent genotypes were HPV-52, HPV-16, and HPV-58. Single high-risk HPV infection peaked in the 36-45 age group, while multiple high-risk HPV infection decreased with age (P-trend < 0.01). Prevalence in the ≤ 25 age group was 3.7%. Single low-risk HPV infection also decreased with age (P-trend = 0.03). Genotypes covered by the nonavalent vaccine had the highest prevalence, increasing with age. Co-infection of HPV-16 with HPV-52 and HPV-58 was common. Single HPV infections were prevalent in cases of urethritis (30.8%), anogenital warts (36.4%), and genital warts (26.3%), while multiple HPV infections were significant in anogenital warts (18.2%).</p><p><strong>Conclusions: </strong>Single HPV infection was predominant in Chongqing, with HPV-52, HPV-16, HPV-58, HPV-53, and HPV-39 being the most prevalent genotypes. The prevalence of genotypes covered by the nonavalent vaccine increased with age. This study offers valuable insights for developing male-specific HPV prevention strategies in Chongqing.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding bacterial diversity, infection dynamics, prevention of antibiotic resistance: an integrated study in an Algerian hospital context. 了解细菌多样性、感染动态、预防抗生素耐药性:阿尔及利亚医院综合研究。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-01 Epub Date: 2024-08-13 DOI: 10.1007/s10096-024-04919-3
Meriem Adouane, Nabil Kadri, Nourelimane Benzitoune, Chafika Lakhdari, Samia Djellal, Lilla Ousmer, Hichem Tahraoui, Abdeltif Amrane, Hocine Remini, Farid Dahmoune, Khodir Madani

Purpose: Bacterial infections, particularly bacteremia, urinary tract infections (UTIs), and pus infections, remain among hospitals' most worrying medical problems. This study aimed to explore bacterial diversity, infection dynamics, and antibiotic resistance profiles of bacterial isolates.

Methods: We analyzed data from 1750 outpatients and 920 inpatients, of whom 1.6% and 8.47% respectively had various bacterial infections.

Results: The analysis revealed that UTIs were the most prevalent at 41.01%, particularly affecting women. UTIs also showed a distinct distribution across admission departments, notably in emergency (23.07%) and pediatric (14.10%) units. The most frequently isolated microorganisms were Escherichia coli (E. coli), followed by Klebsiella ornithinolytica. Skin infections followed UTIs, accounting for 35.88% of cases, more prevalent in men, with Staphylococcus aureus (S. aureus) being the primary pathogen (57%). Gram-negative bacteria (GNB) like E. coli and Pseudomonas aeruginosa contributed significantly to skin infections (43%). Bacteremia cases constituted 11.52% of bacterial infections, predominantly affecting women (67%) and linked to GNB (78%). A comparative study of antibiotic susceptibility profiles revealed more pronounced resistance in GNB strains isolated from inpatients, particularly to antibiotics such as Amoxicillin/clavulanic acid, Tetracyclin, Gentamicin, Chloramphenicol, and Ampicillin. In contrast, strains from ambulatory patients showed greater resistance to Colistin. Gram-positive bacteria from hospitalized patients showed higher resistance to quinolones and cephalosporins, while ambulatory strains showed high resistance to aminoglycosides, macrolides, fluoroquinolones, and penicillin. Furthermore, these analyses identified the most effective antibiotics for the empirical treatment of both community-acquired and nosocomial infections. Ciprofloxacin, aztreonam, and amikacin exhibited low resistance rates among GNB, with gentamicin and chloramphenicol being particularly effective for community-acquired strains. For S. aureus, ciprofloxacin, rifampicin, and cefoxitin were especially effective, with vancomycin showing high efficacy against community-acquired isolates and fosfomycin and chloramphenicol being effective for hospital-acquired strains.

Conclusion: These results are essential for guiding antibiotic therapy and improving clinical outcomes, thus contributing to precision medicine and antimicrobial stewardship efforts.

目的:细菌感染,尤其是菌血症、尿路感染(UTI)和化脓性感染,仍然是医院最令人担忧的医疗问题之一。本研究旨在探讨细菌分离物的多样性、感染动态和抗生素耐药性概况:我们分析了 1750 名门诊病人和 920 名住院病人的数据,其中分别有 1.6% 和 8.47% 的病人患有各种细菌感染:结果:分析结果显示,UTI 的发病率最高,达到 41.01%,尤其是女性。尿毒症在各入院科室也有明显的分布,尤其是急诊科(23.07%)和儿科(14.10%)。最常分离出的微生物是大肠埃希氏菌(E. coli),其次是鸟疫克雷伯菌(Klebsiella ornithinolytica)。皮肤感染紧随UTI之后,占病例总数的35.88%,男性发病率更高,金黄色葡萄球菌(S. aureus)是主要病原体(57%)。大肠杆菌和铜绿假单胞菌等革兰氏阴性菌(GNB)是皮肤感染的主要病原体(43%)。菌血症病例占细菌感染病例的 11.52%,主要影响女性(67%),并与革兰氏阴性菌(78%)有关。一项关于抗生素敏感性的比较研究显示,从住院病人中分离出的 GNB 菌株具有更明显的耐药性,尤其是对阿莫西林/克拉维酸、四环素、庆大霉素、氯霉素和氨苄西林等抗生素。相比之下,非住院病人的菌株对可乐定的耐药性更强。住院病人的革兰氏阳性细菌对喹诺酮类和头孢菌素的耐药性较高,而非住院病人的菌株对氨基糖苷类、大环内酯类、氟喹诺酮类和青霉素的耐药性较高。此外,这些分析还确定了经验性治疗社区获得性感染和医院内感染的最有效抗生素。环丙沙星、阿曲南和阿米卡星在 GNB 中的耐药率较低,庆大霉素和氯霉素对社区获得性菌株尤为有效。对于金黄色葡萄球菌,环丙沙星、利福平和头孢西丁特别有效,万古霉素对社区获得的分离菌株有较高疗效,而磷霉素和氯霉素对医院获得的菌株有效:这些结果对于指导抗生素治疗和改善临床疗效至关重要,从而有助于精准医疗和抗菌药物监管工作。
{"title":"Understanding bacterial diversity, infection dynamics, prevention of antibiotic resistance: an integrated study in an Algerian hospital context.","authors":"Meriem Adouane, Nabil Kadri, Nourelimane Benzitoune, Chafika Lakhdari, Samia Djellal, Lilla Ousmer, Hichem Tahraoui, Abdeltif Amrane, Hocine Remini, Farid Dahmoune, Khodir Madani","doi":"10.1007/s10096-024-04919-3","DOIUrl":"10.1007/s10096-024-04919-3","url":null,"abstract":"<p><strong>Purpose: </strong>Bacterial infections, particularly bacteremia, urinary tract infections (UTIs), and pus infections, remain among hospitals' most worrying medical problems. This study aimed to explore bacterial diversity, infection dynamics, and antibiotic resistance profiles of bacterial isolates.</p><p><strong>Methods: </strong>We analyzed data from 1750 outpatients and 920 inpatients, of whom 1.6% and 8.47% respectively had various bacterial infections.</p><p><strong>Results: </strong>The analysis revealed that UTIs were the most prevalent at 41.01%, particularly affecting women. UTIs also showed a distinct distribution across admission departments, notably in emergency (23.07%) and pediatric (14.10%) units. The most frequently isolated microorganisms were Escherichia coli (E. coli), followed by Klebsiella ornithinolytica. Skin infections followed UTIs, accounting for 35.88% of cases, more prevalent in men, with Staphylococcus aureus (S. aureus) being the primary pathogen (57%). Gram-negative bacteria (GNB) like E. coli and Pseudomonas aeruginosa contributed significantly to skin infections (43%). Bacteremia cases constituted 11.52% of bacterial infections, predominantly affecting women (67%) and linked to GNB (78%). A comparative study of antibiotic susceptibility profiles revealed more pronounced resistance in GNB strains isolated from inpatients, particularly to antibiotics such as Amoxicillin/clavulanic acid, Tetracyclin, Gentamicin, Chloramphenicol, and Ampicillin. In contrast, strains from ambulatory patients showed greater resistance to Colistin. Gram-positive bacteria from hospitalized patients showed higher resistance to quinolones and cephalosporins, while ambulatory strains showed high resistance to aminoglycosides, macrolides, fluoroquinolones, and penicillin. Furthermore, these analyses identified the most effective antibiotics for the empirical treatment of both community-acquired and nosocomial infections. Ciprofloxacin, aztreonam, and amikacin exhibited low resistance rates among GNB, with gentamicin and chloramphenicol being particularly effective for community-acquired strains. For S. aureus, ciprofloxacin, rifampicin, and cefoxitin were especially effective, with vancomycin showing high efficacy against community-acquired isolates and fosfomycin and chloramphenicol being effective for hospital-acquired strains.</p><p><strong>Conclusion: </strong>These results are essential for guiding antibiotic therapy and improving clinical outcomes, thus contributing to precision medicine and antimicrobial stewardship efforts.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ten years of detecting Neoehrlichia mikurensis infections in Sweden: demographic, clinical and inflammatory parameters. 瑞典检测米库雷氏新埃希氏菌感染的十年:人口、临床和炎症参数。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-01 Epub Date: 2024-08-13 DOI: 10.1007/s10096-024-04909-5
Christine Wennerås, Linda Wass, Beatrice Bergström, Anna Grankvist, Christine Lingblom

Purpose: To increase knowledge about the varied clinical manifestations of human infection with the emerging tick-borne pathogen Neoehrlichia mikurensis.

Methods: All patients diagnosed in Sweden with N. mikurensis infection during a 10-year period (2013-2023) were investigated regarding their demographic factors, risk factors, comorbidities, clinical signs and symptoms, and laboratory results. Multivariate models were generated using "Orthogonal Projections to Latent Structures-Discriminant Analysis" to identify clinical and immune parameters associated with N. mikurensis infection.

Results: During the 10-year period, 134 patients were diagnosed with N. mikurensis infection, 102 of whom were included in this study. Most of the patients (79%) were immunosuppressed. The main comorbidities were malignant B-cell lymphomas, multiple sclerosis, and rheumatoid arthritis. Rituximab therapy (59%) and splenectomy (14%) featured prominently. All patients resided in the southern tick-endemic part of Sweden, yet one-third of them were diagnosed in wintertime when ticks are inactive. Two asymptomatically infected blood donors were identified but transfusion-transmitted infection was not confirmed. Increased levels of C-reactive protein, orosomucoid, and total IgM in serum were associated with neoehrlichiosis. Previously unreported symptoms such as ankle edema, neck pain, numbness, and sudden deafness were detected in some patients. One case of aplastic anemia partially improved after eradication of the infection.

Conclusions: Neoehrlichiosis is a multi-faceted emerging infectious disease.

目的:了解人类感染新出现的蜱媒病原体Neoehrlichia mikurensis后的各种临床表现:调查了瑞典在 10 年内(2013-2023 年)确诊感染 N. mikurensis 的所有患者的人口统计学因素、风险因素、合并症、临床症状和体征以及实验室结果。利用 "潜结构正交投影-判别分析 "生成多变量模型,以确定与 N. mikurensis 感染相关的临床和免疫参数:结果:10 年间,134 名患者被诊断为 N. mikurensis 感染,其中 102 人被纳入本研究。大多数患者(79%)都有免疫抑制。主要合并症为恶性B细胞淋巴瘤、多发性硬化症和类风湿性关节炎。利妥昔单抗疗法(59%)和脾切除术(14%)是主要治疗手段。所有患者都居住在瑞典南部蜱虫流行的地区,但其中三分之一的患者是在蜱虫不活跃的冬季确诊的。发现了两名无症状的受感染献血者,但输血传播感染并未得到证实。血清中C反应蛋白、嗜酸性粒细胞和总IgM水平升高与新毛滴虫病有关。一些患者出现了以前未报告过的症状,如脚踝水肿、颈部疼痛、麻木和突发性耳聋。有一例再生障碍性贫血患者在根除感染后部分好转:结论:新埃希氏菌病是一种多发性新发传染病。
{"title":"Ten years of detecting Neoehrlichia mikurensis infections in Sweden: demographic, clinical and inflammatory parameters.","authors":"Christine Wennerås, Linda Wass, Beatrice Bergström, Anna Grankvist, Christine Lingblom","doi":"10.1007/s10096-024-04909-5","DOIUrl":"10.1007/s10096-024-04909-5","url":null,"abstract":"<p><strong>Purpose: </strong>To increase knowledge about the varied clinical manifestations of human infection with the emerging tick-borne pathogen Neoehrlichia mikurensis.</p><p><strong>Methods: </strong>All patients diagnosed in Sweden with N. mikurensis infection during a 10-year period (2013-2023) were investigated regarding their demographic factors, risk factors, comorbidities, clinical signs and symptoms, and laboratory results. Multivariate models were generated using \"Orthogonal Projections to Latent Structures-Discriminant Analysis\" to identify clinical and immune parameters associated with N. mikurensis infection.</p><p><strong>Results: </strong>During the 10-year period, 134 patients were diagnosed with N. mikurensis infection, 102 of whom were included in this study. Most of the patients (79%) were immunosuppressed. The main comorbidities were malignant B-cell lymphomas, multiple sclerosis, and rheumatoid arthritis. Rituximab therapy (59%) and splenectomy (14%) featured prominently. All patients resided in the southern tick-endemic part of Sweden, yet one-third of them were diagnosed in wintertime when ticks are inactive. Two asymptomatically infected blood donors were identified but transfusion-transmitted infection was not confirmed. Increased levels of C-reactive protein, orosomucoid, and total IgM in serum were associated with neoehrlichiosis. Previously unreported symptoms such as ankle edema, neck pain, numbness, and sudden deafness were detected in some patients. One case of aplastic anemia partially improved after eradication of the infection.</p><p><strong>Conclusions: </strong>Neoehrlichiosis is a multi-faceted emerging infectious disease.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Clinical impact and cost-consequence analysis of ePlex® blood culture identification panels for the rapid diagnosis of bloodstream infections: a single-center randomized controlled trial. 更正:用于血流感染快速诊断的 ePlex® 血培养鉴定板的临床影响和成本后果分析:单中心随机对照试验。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-01 DOI: 10.1007/s10096-024-04924-6
Yvan Caspar, A Deves, C Richarme, M Le Marechal, L Ponderand, A-L Mounayar, S Lejeune, J Arata-Bardet, M Gallouche, C Recule, D Maubon, C Garnaud, M Cornet, M Veloso, B Chabani, M Maurin, S David-Tchouda, P Pavese
{"title":"Correction to: Clinical impact and cost-consequence analysis of ePlex® blood culture identification panels for the rapid diagnosis of bloodstream infections: a single-center randomized controlled trial.","authors":"Yvan Caspar, A Deves, C Richarme, M Le Marechal, L Ponderand, A-L Mounayar, S Lejeune, J Arata-Bardet, M Gallouche, C Recule, D Maubon, C Garnaud, M Cornet, M Veloso, B Chabani, M Maurin, S David-Tchouda, P Pavese","doi":"10.1007/s10096-024-04924-6","DOIUrl":"10.1007/s10096-024-04924-6","url":null,"abstract":"","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142105585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Clinical Microbiology & Infectious Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1